A Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of Brexanolone in the Treatment of Adolescent Female Subjects With Postpartum Depression
Phase of Trial: Phase III
Latest Information Update: 02 Nov 2018
At a glance
- Drugs Brexanolone (Primary)
- Indications Postnatal depression
- Focus Therapeutic Use
- Sponsors Sage Therapeutics
- 05 Oct 2018 Planned number of patients changed from 40 to 80.
- 20 Sep 2018 Status changed from planning to recruiting.
- 15 Feb 2017 New trial record